The Federal Trade Commission (FTC) has finalized a consent order with Welsh, Carson, Anderson & Stowe and its affiliates, collectively known as Welsh Carson. This action resolves a potential administrative antitrust case against the firm.
The FTC had charged that Welsh Carson, through its portfolio company U.S. Anesthesia Partners (USAP), engaged in acquisitions that suppressed competition and increased prices for anesthesiology services in Texas.
As part of the final consent order, Welsh Carson is required to reduce its involvement with USAP. Additionally, they must notify the FTC about specified future acquisitions and investments related to anesthesia and other hospital-based physician practices.
This decision follows a federal lawsuit filed by the FTC against USAP and Welsh Carson in September 2023. The lawsuit claimed that USAP and Welsh Carson systematically acquired nearly every large anesthesia practice in Texas to form a single dominant provider.
Welsh Carson was dismissed from this federal case in May 2024, but the FTC's case against USAP continues in court.
After a public comment period, the Commission unanimously approved the final order with a 3-0 vote.
The Federal Trade Commission's mission includes promoting competition while protecting and educating consumers. They emphasize that they will never request money or make threats. More information on how competition benefits consumers or how to file an antitrust complaint can be found on their website. For updates, follow the FTC on social media or subscribe to their press releases and blog.
